Hangzhou Shenshi Energy Conservation Technology Co.,Ltd announced that it has received CNY 200 million in funding from Zhejiang Yinxinggu Investment Co, Ltd., Guobang Pharma Ltd., Beiqi Foton Motor Co.,Ltd., China V Fund Management Co., Ltd., Gold Stone Investment Co., Ltd. and other investors.

Guobang Pharma Ltd is a China-based company mainly engaged in the research and development, production, and sales of related products in the field of medicine and animal health products. The Company's pharmaceutical business includes raw materials, key pharmaceutical intermediates and preparations, and its main products include azithromycin, clarithromycin, and roxithromycin cephalosporin series products. The animal health products business includes animal protection raw materials, animal protection additives and preparations. The main products of veterinary antibiotics include florfenicol, enrofloxacin series, etc., and insecticides include diclazuril and cypronamine, and reparation products include premixes, powders, granules, etc.